Dominick Colangelo Vericel Corp (VCEL) insider trading activity

Dominick Colangelo is President and CEO of Vericel Corp. Currently has a direct ownership of 260,354 shares of VCEL, which is worth approximately $10.2 Million. The most recent transaction as insider was on Apr 10, 2025, when has been sold 24,850 shares (Common Stock) at a price of $41.89 per share, resulting in proceeds of $1,040,966. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 260K

17.84% 3M change

17.94% 12M change

Total Value Held $10.2 Million

Dominick Colangelo Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 10 2025	SELL Open market or private sale	$1,040,966 $41.89 p/Share	24,850 Reduced 8.71%	260,354 Common Stock
Apr 10 2025	BUY Exercise of conversion of derivative security	$68,337 $2.75 p/Share	24,850 Added 8.01%	285,204 Common Stock
Apr 09 2025	SELL Open market or private sale	$1,021,583 $41.11 p/Share	24,850 Reduced 8.71%	260,354 Common Stock
Apr 09 2025	BUY Exercise of conversion of derivative security	$68,337 $2.75 p/Share	24,850 Added 8.01%	285,204 Common Stock
Mar 13 2025	SELL Open market or private sale	$1,217,381 $45.78 p/Share	26,592 Reduced 9.28%	259,997 Common Stock
Mar 13 2025	BUY Exercise of conversion of derivative security	$51,854 $1.95 p/Share	26,592 Added 8.49%	286,589 Common Stock
Mar 12 2025	SELL Open market or private sale	$1,231,429 $46.31 p/Share	26,591 Reduced 9.28%	259,997 Common Stock
Mar 12 2025	BUY Exercise of conversion of derivative security	$51,852 $1.95 p/Share	26,591 Added 8.49%	286,588 Common Stock
Feb 24 2025	SELL Payment of exercise price or tax liability	$442,659 $52.33 p/Share	8,459 Reduced 3.15%	259,997 Common Stock
Feb 24 2025	BUY Exercise of conversion of derivative security	-	18,250 Added 6.37%	268,456 Common Stock
Feb 19 2025	SELL Payment of exercise price or tax liability	$242,444 $57.78 p/Share	4,196 Reduced 1.65%	250,206 Common Stock
Feb 19 2025	BUY Exercise of conversion of derivative security	-	8,938 Added 3.39%	254,402 Common Stock
Feb 18 2025	SELL Payment of exercise price or tax liability	$310,629 $57.28 p/Share	5,423 Reduced 2.16%	245,464 Common Stock
Feb 18 2025	BUY Exercise of conversion of derivative security	-	29,950 Added 10.66%	250,887 Common Stock
Nov 14 2024	SELL Open market or private sale	$943,775 $53.93 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Nov 14 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Nov 13 2024	SELL Open market or private sale	$972,475 $55.57 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Nov 13 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Oct 17 2024	SELL Open market or private sale	$705,950 $40.34 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Oct 17 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Oct 16 2024	SELL Open market or private sale	$724,150 $41.38 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Oct 16 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Sep 12 2024	SELL Open market or private sale	$768,250 $43.9 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Sep 12 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Sep 11 2024	SELL Open market or private sale	$758,975 $43.37 p/Share	17,500 Reduced 7.34%	220,937 Common Stock

Also insider at

TRVI

Trevi Therapeutics, Inc. Healthcare